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Introduction
Millions of  patients receive blood transfusions worldwide, with nearly 15 million units collected in the 
U.S. alone. Of  the units collected, approximately one-fifth of  RBCs remain in storage for as long as 4 to 
6 weeks (1), making the safety of  these storage units difficult to evaluate in humans (2) and prompting 
the U.S. NIH to reduce maximum FDA allowable storage limits from 42 days to 35 days (3). Several 
retrospective and prospective studies have assessed organ injury or morbidity, length of  hospital stay, 
number of  ventilator days, and all-cause mortality in patients transfused with blood after different storage 
periods (4–8). While some of  these retrospective studies reported worse clinical outcome associated with 
transfusion of  blood after a longer storage period (4, 5), another large cohort study found only a mar-
ginal increase in 7-day mortality after stored blood transfusion, which disappeared when the analysis was 
restricted to leukoreduced RBCs (9). Prospective clinical trials in different patient populations have also 
not confirmed the initial findings of  increased morbidity and mortality after stored RBC transfusion (6, 7). 
These randomized trials reported that older stored blood compared with fresh blood did not alter clinical 
outcomes (6, 7, 10) or surrogate markers of  tissue oxygenation (11) in patients undergoing cardiac surgery 
as well as in critically ill adults and infants.
Preclinical models provide a unique opportunity to evaluate potential adverse effects of  transfusion 
with RBC units approaching the end of  the allowed storage period. Such data may not otherwise be obtain-
able from human trials. While preclinical studies cannot provide quantitative estimates of  the clinical risk 
in different human transfusion scenarios, they can reveal insight into pathophysiological mechanisms of  
RBC transfusion–related toxicity and enhance understanding of  the relationship between storage time, 
RBC units dosed, and underlying disease.
Non–transferrin-bound iron (NTBI) and free hemoglobin (Hb) accumulate in circulation following 
stored RBC transfusions. This study investigated transfusion, vascular disease, and mortality in 
guinea pigs after stored RBC transfusion alone and following cotransfusion with apo-transferrin 
(apo-Tf) and haptoglobin (Hp). The effects of RBC exchange transfusion dose (1, 3, and 9 units), 
storage period (14 days), and mortality were evaluated in guinea pigs with a vascular disease 
phenotype. Seven-day mortality and the interaction between iron and Hb as cocontributors to 
adverse outcome were studied. Concentrations of iron and free Hb were greatest after transfusion 
with 9 units of stored RBCs compared with fresh RBCs or stored RBCs at 1- and 3-unit volumes. 
Nine units of stored RBCs led to mortality in vascular diseased animals, but not normal animals. 
One and 3 units of stored RBCs did not cause a mortality effect, suggesting the concomitant 
relevance of NTBI and Hb on outcome. Cotransfusion with apo-Tf or Hp restored survival to 100% 
following 9-unit RBC transfusions in vascular diseased animals. Our data suggest that increases in 
plasma NTBI and Hb contribute to vascular disease–associated mortality through iron-enhanced Hb 
oxidation and enhanced tissue injury.
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When they occur, pathological responses to the transfusion of  blood are complex, multifactorial, and 
complicated by comorbidities such as vascular disease. In animals the unintended consequences of  RBC 
transfusion may be associated with extravascular hemolysis leading to non–transferrin-bound iron (NTBI) 
accumulation (12), intravascular hemolysis leading to release of  free hemoglobin (Hb) (13), and ischemia 
reperfusion injury (14). In animals, these processes are reported to deregulate vascular nitric oxide (NO) 
homeostasis (15–17), promote inflammation (12), and exacerbate infection (18, 19). In humans, posttrans-
fusion saturation of  transferrin (Tf) increases and NTBI accumulates in plasma as a result of  extravascular 
hemolysis, taking place in the spleen and liver (20, 21). As the number of  RBC units administered increases, 
depletion of  haptoglobin (Hp) levels leads to accumulation of  cell-free Hb in plasma (22). Together, iron 
and Hb may lead to undesirable effects reported to occur following transfusion of  older storage time blood.
In the present study, we hypothesized that transfusion of  stored RBCs could increase mortality in guin-
ea pigs with a diet-induced vascular disease phenotype and that outcome may be determined by both iron 
and Hb accumulation. We further studied if  neutralization of  iron and Hb by administration of  the binding 
proteins Tf  (as apo-Tf) and Hp, respectively, could be used to improve survival in our model. Herein we 
present data to support that neutralization of  iron and cell-free Hb improves outcome following transfusion 
of  stored guinea pig RBCs. Our data suggest that increases in plasma NTBI and Hb contribute to vascular 
disease–associated mortality though iron-enhanced Hb oxidation and subsequent tissue injury.
Results
Guinea pig model of  preexisting vascular disease: vascular remodeling and endothelial dysfunction. Compared 
with normal diet (ND), our high-fat and high-sucrose diet (HFSD) guinea pigs developed structural 
changes in elastic arteries, characterized by increased collagen in medial and adventitial layers of  aorta 
sections stained with Masson’s trichrome (Figure 1A). In addition, HFSD guinea pigs demonstrated a 
fragmented pattern or complete loss of  elastin fibers with increased collagen deposition in Verhoeff-
Van Gieson–stained aorta tissue sections (Figure 1A). The ratio of  collagen to elastin was evaluated to 
determine the extent of  remodeling within the aorta. The data demonstrate a 2.5-fold increase in aortic 
collagen (39.2% ± 3.78 %) in HFSD compared with ND (15.3% ± 4.87 %) guinea pigs (Figure 1B) and 
a 7-fold increase in the aortic collagen to elastin ratio following 3 months of  HFSD (1.86 ± 0.496) com-
pared with ND (0.300 ± 0.127) in guinea pigs (Figure 1C). The loss of  elastin or its fragmentation as 
well as collagen deposition are critical components of  vascular dysfunction and increased blood vessel 
stiffness, particularly in the central elastic vessels (23).
To measure the effect of  a HFSD on vascular function, blood pressure was measured from an 
indwelling catheter placed in the common carotid artery. In all HFSD guinea pigs, baseline systolic and 
pulse pressures were consistently elevated compared with ND animals (Figure 1, D and E). Addition-
ally, sequential injections of  acetylcholine (Ach) were made over a dosing range from 0 to 10 μg to ND 
and HFSD guinea pigs. Systolic and diastolic blood pressures were allowed to return to basal values 
prior to each subsequent Ach dose, consistent with endothelial dysfunction. Ach at each dosing level 
was consistently less vasodilatory in HFSD animals (–15.7% ± 7.74% [2.50 μg], –21.4% ± 8.39% [5 
μg], and –28.0% ± 6.91% [10 μg]) compared with ND animals (–56.0% ± 12.3% [2.50 μg], –55.5% ± 
6.67% [5 μg], and –69.7% ± 7.23% [10 μg]) (Figure 1F). Similar to diabetic mice (24, 25), HFSD guinea 
pigs demonstrated increased systemic blood pressure following stored-RBC (S-RBC; stored for 14 days) 
compared with fresh-RBC (F-RBC; used within 1 day of  collection) transfusion. The blood pressure 
response to S-RBC transfusion was blunted following coadministration of  high-dose Hp (300 mg/kg), 
suggesting that increased Hb induced vasoactivity despite endothelial dysfunction, also similar to dia-
betic mice. This hemodynamic response in HFSD guinea pigs was associated with Hb-induced expres-
sion of  inactive eNOS (Supplemental Figure 1; supplemental material available online with this article; 
https://doi.org/10.1172/jci.insight.93577DS1). These characteristics mimic a frequent cardiovascular 
comorbidity found in patients undergoing blood transfusion (26).
Transfusion of  stored guinea pig RBCs leads to dose-dependent accumulation of  plasma iron and cell-free Hb. 
Storage parameters and posttransfusion survival were tested for F-RBCs and S-RBCs (Table 1). Data 
presented in Table 1 show the mean ± SD (95% CI) differences in guinea pig RBC parameters following 
overnight storage (day 1) compared with storage for 14 days. In the present study blood, was collected 
in anticoagulant citrate phosphate double dextrose (CP2D) and RBCs were stored in additive solution 
formula 3 (AS-3). The trends in RBC parameter changes for human blood after collection in CP2D and 
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Figure 1. Vascular remodeling and endothelial dysfunction are increased in guinea pigs on 
a high-fat and high-sucrose diet (HFSD) compared with normal diet (ND) animals. (A) Light 
microscopy images of representative aorta sections from guinea pigs after 3 months on either 
ND or HFSD shown in the upper panel were stained with Masson’s trichrome (collagen = blue); 
sections in the lower panel were stained with the Verhoeff’s Van Giesen method (elastin fibers 
= black/brown; collagen fibers = red). Images were obtained at ×100 magnification and show 
increased visualization of collagen staining and elastin fragmentation in the vascular media. 
Scale bars: 100 μm. (B) Percentage area of collagen-positive staining was increased in aortas 
after 3 months on HFSD (filled circles) compared with ND (open circles) (n = 10, P = 0.0001 by 
a 2-tailed t test). (C) Collagen/elastin ratios were significantly increased in ND compared with 
HFSD (n = 10, P = 0.0001 by a 2-tailed t test); both are indicative of remodeling in elastic arteries. 
Both (D) systolic blood pressure and (E) pulse pressure significantly increased in HFSD (filled 
circles) compared with ND (open circles) guinea pigs (n = 12, P = 0.0001 (systolic blood pressure) 
by a 2-tailed t test) and (n = 12, P = 0.0001 (pulse pressure) by a 2-tailed t test). (F) Systemic 
vascular responsiveness (mean arterial blood pressure) in response to acetylcholine doses was 
significantly lower in HFSD (n = 12, closed circles) compared with ND guinea pigs (n = 12, open cir-
cles), suggesting significantly reduced endothelial NO availability. ND and HFSD guinea pig mean 
arterial pressure responses following an ANOVA with a multiple comparisons test demonstrated 
significant differences between groups †(0, 2.5, 5.0, and 10 μg): P = 0.9999 (0 μg), P = 0.0001 
(2.5 μg), P = 0.0001 (5.0 μg), P = 0.0001 (10 μg). *P = 0.0001 compared with baseline. All data are 
presented as individual values with the mean ± SD. Magnification = ocular lens (×10) × objective.
4insight.jci.org   https://doi.org/10.1172/jci.insight.93577
R E S E A R C H  A R T I C L E
storage in AS-3 have been performed elsewhere (27) and general comparisons may be useful to the read-
er. The normal discocyte morphology of  guinea pig RBCs under scanning electron microscopy on stor-
age day 1 (Figure 2A) shows pronounced echinocyte/spheroechinocyte forms by day 14 (Figure 2B).
The maximal plasma NTBI concentration after transfusion with 9 units (RBCs administered are 
referred to here as units rather than mls of  total volume exchange transfused) of  S-RBCs (260 ± 80.6 
μg/l) was significantly increased compared with NTBI concentration following transfusion with 9 units of  
F-RBCs (50.0 ± 20.3 μg/l). Administration of  apo-Tf  (63.4 ± 6.77 μg/l), but not Hp (322.0 ± 25.1 μg/l) 
at the time of  9-unit S-RBC transfusion prevented NTBI accumulation in plasma (Figure 2C). Interest-
ingly, 1- and 3-unit transfusion of  S-RBCs generated similar plasma NTBI concentrations to that of  9-unit 
transfusion (Figure 2C), but did not lead to mortality or tissue injury in the 1- or 3-unit dosing groups. In 
cotransfused animals, the average maximum plasma concentration of  apo-Tf  was 20.1 ± 3.98 mg/ml and 
this level declined over 24 hours. Saturation of  the infused apo-Tf  increased from 0% to 8.10% ± 3.68%, 
while NTBI was maintained at pretransfusion levels (Figure 2D). Areas under the NTBI plasma concen-
tration versus time curves (AUC0–24 NTBI) show no difference between 1, 3, and 9 units transfused in this 
model (Figure 2E).
Appearance and accumulation of  plasma Hb was not observed following transfusion of  1 or 3 units of  
S-RBCs. However, plasma Hb levels increased to 1.45 ± 0.45 mg/ml over the 24 hours after 9 units of  S-RBC 
transfusion (Figure 2F). Free Hb in the plasma remained at control levels (0.012 ± 0.010 mg/ml) with the 
administration of  Hp at the time of  transfusion (Figure 2F). Plasma levels of  infused Hp reached a maxi-
mum concentration of  1.97 ± 0.0810 mg/dl (Figure 2G) and these concentrations exceeded total plasma Hb 
concentrations over the course of  the study, maintaining Hb in a Hb-Hp complex (Figure 2G, inset). Plasma 
and RBC Hb levels were predominantly in the ferrous (HbFe2+) nonoxidized state after transfusion.
Hp and apo-Tf  administration prevent stored RBC transfusion–related mortality in guinea pigs with preexisting 
vascular remodeling and endothelial dysfunction. Vascular dysfunction–phenotype HFSD animals (n = 10) were 
dosed with either 9 units of  F-RBCs or 1, 3, or 9 units of  S-RBC (n = 10/group). Animals were monitored 
over the 7 days after transfusion for the onset of  humane end-point parameters (labored breathing, shivering 
with ruffled fur, ataxia with impaired mobility, and inability to reach food and water) and survival. Transfu-
sion with 9 units of  S-RBCs led to a significant (P = 0.0005) reduction of  7-day survival (40%, 4 survivors 
out of  10) in HFSD guinea pigs compared with ND guinea pigs (Figure 3A). In contrast, transfusion with 9 
Table 1. RBC storage testing parameters
Analyzed  Storage day 1 — Fresh blood 
(Mean ± SD, 95% CI) (n = 4 bags)
Storage day 14 — Stored blood 
(Mean ± SD, 95% CI) (n = 4 bags)
2,3-DPG (μmol/g Hb) 9.39 ± 1.40 (7.16, 11.6) 1.65 ± 0.116 (1.47, 1.84)A
ATP (μmol/g Hb) 6.53 ± 0.424 (5.86, 7.20) 1.30 ± 0.534 (0.415, 2.11)A
Hb (% free) 0.262 ± 0.0215 (0.228, 0.296) 0.830 ± 0.057 (0.651, 1.00)A
Lactate (mmol/l) 1.68 ± 0.0500 (1.60, 1.76) 13.9 ± 0.287 (13.5, 14.4)A
Glucose (g/dl)B 123 ± 30.9 (73.3, 172) 233 ± 31.6 (183, 283)A
Na+ (mmol/l) 149 ± 1.71 (146, 152) 151 ± 1.29 (148, 153)
Cl– (mmol/l) 90.2 ± 1.27 (88.2, 92.2) 93.9 ± 0.210 (93.2, 94.5)A
K+ (mmol/l) 6.03 ± 0.0957 (5.87, 6.18) 8.16 ± 0.103 (7.99, 8.32)A
RBC count (M/μl) 6.13 ± 0.990 (4.43, 7.70) 5.32 ± 0.423 (4.64, 5.99)
MCV (fl) 81.3 ± 0.419 (80.7, 82.0) 81.9 ± 0.351 (81.3, 82.4)
HCT% 60.5 ± 3.1 (55.6, 65.5) 58.8 ± 2.87 (54.2, 63.3)
WBC count (K/μl) 0.0188 ± 0.0262 (0.0231, 0.0606) 0.00700 ± 0.00294 (0.00232, 0.00147)
Platelet count (K/μl) 0.115 ± 0.145 (0.116, 0.345) 0.426 ± 0.0329 (0.373, 0.478)A
Deformability (EI)C 0.376 ± 0.010 (0.351, 0.401) 0.208 ± 0.010 (0.183, 0.232)A
RBC recovery in vivo (%) (24 hours) 95.7 ± 6.10 (91.1, 100) 76.3 ± 11.0 (67.2, 86.0)A
AIndicates significant between-group differences. BBlood collected in anticoagulant citrate phosphate double dextrose and stored in additive solution 
formula 3. CEI = elongation index at 3 Pa of shear. Day 1 versus day 14 of storage (4 separate bags per time point): 2,3-DPG, P = 0.0001; ATP, P = 0.0001; Hb 
(% free), P = 0.0001; lactate, P = 0.0001; glucose, P = 0.00250; Na+, P = 0.287; Cl–, P = 0.0015; K+, P = 0.0001; RBC count, P = 0.186; MCV, P = 0.103; HCT%, 
P = 0.440; WBC count, P = 0.409; Platelet count, P = 0.0057; RBC recovery, P = 0.0005. 2,3-DPG, 2,3,-diphosphoglycerate; Hb, hemoglobin; MCV, mean 
corpuscular volume; HCT%, hematocrit (%).
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units of  F-RBCs as well as lower doses of  S-RBCs (1 and 3 units) had no effect on 7-day survival (Figure 3B). 
Additionally, we did not observe any deaths after transfusion of  9 units of  S-RBCs in healthy ND guinea pigs.
Administration of  Hp or apo-Tf  at the time of  transfusion rescued HFSD animals receiving 9 units 
of  S-RBC transfusion to 100% (10 of  10 animals) survival (Figure 3B). In representative animals having 
expired after 9 units of  S-RBC transfusion, pathological changes were associated with large vessel throm-
bus deposition observed in regions of  the aorta (Figure 3C), accentuated vascular injury (elastin fragmen-
tation and collagen deposition) (Figure 3, D and E), renal cortex proximal and distal tubule necrosis, and 
finally glomerular capillary thrombosis (Figure 3F).
Free iron enhances the oxidation of  free Hb, leading to tissue oxidation and injury. Because NTBI was the same 
at 1, 3, and 9 units of  S-RBC transfusion and free Hb only increased after transfusion of  9 units of  S-RBCs, 
we tested the concept that free iron increases the rate of  oxidation of  Hb in vitro and in vivo. We first tested 
the spectrally derived autoxidation from ferrous Hb (HbFe2+) to ferric Hb (HbFe3+) by adding 50 μM iron as 
Figure 2. Plasma iron and cell-free hemoglobin 
(Hb) following fresh red blood cell (F-RBC) 
and stored red blood cell (S-RBC) transfusion 
in guinea pigs is prevented with infusion of 
apo-transferrin (apo-Tf) and haptoglobin (Hp), 
respectively. (A and B) Electron microscopy 
images of donor guinea pig RBCs on storage 
day 1 and storage day 14, respectively. Scale 
bars: 5 μm. Original magnification, ×5,000. (C) 
Maximum plasma non–transferrin-bound iron 
(NTBI) concentrations (Cmax) were significantly 
increased following 9-unit transfusion of S-RBCs 
compared with F-RBCs (n = 10, P = 0.0001), coad-
ministration with apo-Tf significantly decreased 
NTBI (n = 10, P = 0.0001), while Hp had no effect 
on plasma NTBI levels. Significant increases 
in plasma NTBI were also observed following 
F-RBC transfusion compared with S-RBC + Hp 
(n = 10, P = 0.0001) and between S-RBC + apo-Tf 
and S-RBC + Hp (n = 10, P = 0.0001). (D) Plasma 
apo-Tf concentrations (n = 5) versus time (blue, 
left axis) and the saturation of infused apo-Tf 
(n = 5, right gray axis) are shown for qualitative 
visualization. (E) NTBI plasma concentration 
versus time areas (AUCs) show no difference 
between 1, 3, and 9 units of S-RBCs in this mod-
el. Transfusion with S-RBCs at 1, 3, and 9 units, 
and 9 units + Hp significantly increased plasma 
NTBI compared with 9 units S-RBCs + apo-Tf (n = 
10, P = 0.0001). (F) Maximum plasma Hb concen-
trations (Cmax) increased compared with 9-unit 
F-RBC transfusion as follows: 9 units F-RBCs 
versus 9 units S-RBCs (n = 10, P = 0.0140); 9 
units F-RBCs versus 9 units S-RBCs + apo-Tf (n = 
10, P = 0.0210). While Hp significantly decreased 
maximum Hb concentrations compared with 
9 units S-RBCs (n = 10, P = 0.0151) and 9 units 
S-RBCs + apo-Tf (n = 10, P = 0.0191). (G) Plasma 
Hp concentrations (blue, left axis) and mean 
plasma Hb concentrations (mg/ml) after trans-
fusion with 9 units S-RBCs (red line/area, right 
axis) are shown to qualitatively demonstrate 
that Hp exceeds Hb at all time points. Inset  is 
a representative size-exclusion chromatograph 
showing that all Hb is bound to Hp (red trace rep-
resents Hb and blue trace represents Hb-Hp in 
plasma). All statistical comparisons were made 
using an ANOVA with a multiple comparisons 
test. All data are presented as individual values 
with the mean ± SD.
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Figure 3. Transfusion-related mortality in guinea pigs 
with preexisting vascular remodeling and endothelial 
dysfunction is reversed by apo-transferrin (apo-Tf) and 
haptoglobin (Hp). (A) Nine units S-RBCs significantly 
increased 7-day mortality in high-fat and high-sucrose 
diet (HFSD) but not in normal diet (ND) guinea pigs over 
a 7-day observation period (n = 10, P = 0.0143, by log-rank 
[Mantel-Cox]); data are presented as percentage survival. 
(B) Survival after a 7-day observation period of ND and 
HFSD guinea pigs after different transfusion regimens with 
increasing RBC transfusion dose as indicated. Administra-
tion of apo-Tf (300 mg/kg) and Hp (300 mg/kg) at the time 
of transfusion restores survival in the HFSD animals dosed 
with 9 units of S-RBCs at the highest RBC transfusion 
dose (apo-Tf; n = 10, *P = 0.0001, ANOVA with a multiple 
comparisons test) and (Hp; n = 10, †P = 0.0001, ANOVA with 
a multiple comparisons test). (C) Left panel: H&E staining 
of thoracic aorta showing large thrombi in a nonsurviving 
9-unit S-RBC–transfused animal. Original magnification, 
×400. Scale bar: 200 μm. Right panel: High magnification 
of dashed box region. Original magnification, ×200. Scale 
bar: 50 μm. (D) Left panel: Verhoeff-Van Geison stain-
ing of elastic fibers from the same animal in C. Original 
magnification, ×400. Scale bar: 200 μm. Right panel: High 
magnification of dashed box region showing extensive 
elastin fragmentation indicated by white arrows. Original 
magnification, ×100. Scale bar: 50 μm. (E) Left panel: Mas-
son’s trichrome staining of collagen from the same animal 
in C. Original magnification, ×400. Scale bar: 200 μm. Right 
panel: High magnification of dashed box region showing 
collagen deposition indicated by solid arrows. Original 
magnification, ×100. Scale bar: 50 μm. (F) Left panel: H&E 
staining of renal cortical tissue from a separate nonsurviv-
ing animal showing acute proximal and distal tubule necro-
sis (solid arrow). Original magnification, ×200. Scale bar: 50 
μm.  Right panel: High magnification of dashed box region 
showing loss of renal cortical tubule nuclei (solid arrows) 
and thrombi occurring in the glomerular capillary structure 
(white arrow). Original magnification, ×600. Scale bar: 20 
μm.  All images were captured identically with default set-
tings. Magnification = ocular lens (×10) × objective.
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iron sulfate (FeSO4) to 100 μM Hb (ferrous, HbFe
2+) performed in 3 (n = 3) analytical replicates per group 
at 37°C. All solutions were monitored by UV-visible spectrometry over a 4-hour period. The addition of  
iron resulted in an acceleration in the rate of  autoxidation of  HbFe2+ to HbFe3+ (Hb ox = 7.51 × 10–3 μM/h) 
compared with Hb/FeSO4 (Hb ox = 1.41 × 10
–1 μM/h) (Figure 4, A and B). The addition of  increasing 
amounts of  apo-Tf  (25, 50, and 100 μM) demonstrated a concentration-dependent decrease in the rate of  
Hb oxidation. A maximum reduction of  16-fold in iron-induced Hb oxidation was observed after the addi-
tion of  100 μM apo-Tf  (Hb ox = 3.45 × 10–2 μM/h) (Figure 4, A and B).
To understand if  this in vitro observation had in vivo significance, tissue oxidation was assessed in 
formalin-fixed and paraffin-embedded tissue sections from thoracic aorta and kidney following 9-unit 
S-RBC transfusions (± apo-Tf  or Hp). Immunohistochemistry for detecting lipid peroxide–based tissue 
4-hydroxynonenal (4-HNE) adducts was performed and shows diffuse anti–4-HNE immunoreactivity in 
the aorta of  representative 9-unit S-RBC–transfused animals (Figure 4C). These data are consistent with 
our recent observations (28, 29). Aortic tissue 4-HNE immunoreactivity observed in the 9-unit S-RBC–
transfused group was not observed in animals coadministered apo-Tf  or Hp (Figure 4C). Similar observa-
tions were made in regions of  the renal cortex (Figure 4D).
The effect of  localized oxidation on vascular and renal tissue pathology can be visualized by comparing 
the H&E-stained thoracic aorta and renal cortex following 9-unit S-RBC transfusions alone and 9-unit S-RBC 
(± apo-Tf or Hp). In the thoracic aorta, clear coagulative necrosis is observed following 9-unit S-RBC transfu-
sion. Iron accumulation in the 9-unit S-RBC–transfused animals is observed in the media and adventitia of  
aortic vessels (Figure 5A). Apo-Tf and Hp independently attenuated this effect (Figure 5, A and B). In the 
renal cortex a similar pattern was observed. Increased renal tubule inflammation and necrosis occurred fol-
lowing 9-unit S-RBC transfusion. However, this was also not observed if  apo-Tf or Hp was dosed at the time 
of  transfusion (Figure 5C). The injury marker neutrophil gelatinase–associated lipocalin (NGAL or LCN2) 
mRNA expression was evaluated as a biological marker to suggest acute renal injury. In the 9-unit S-RBC 
transfusion group, a significant NGAL basal increase was observed (17.5 ± 7.85-fold). Conversely, NGAL 
expression was significantly attenuated following 9-unit S-RBC transfusion with apo-Tf (7.46 ± 3.71, fold 
induction over baseline) and Hp (3.23 ± 1.61, fold induction over baseline) administration (Figure 5D).
Discussion
The present study focused on the dose-dependent mortality associated with the transfusion of  older stored 
RBCs, which can represent as much as 20% of  RBC units awaiting transfusion (1). In the model presented, 
we observed that the transfusion dose, the storage age of  the RBC, and preexisting vascular disease are criti-
cal and mutually interactive determinants of  posttransfusion mortality. Posttransfusion release of  Hb and 
NTBI are 2 pathophysiological factors contributing to this end point. Posttransfusion mortality could be 
prevented when cell-free Hb or NTBI were neutralized by their binding proteins Hp or apo-Tf, respectively.
Storage-time-dependent changes of  RBCs are characterized by echinocytic shape changes associated 
with decreased deformability, rapid splenic sequestration, and macrophage clearance (12, 30). Splenic 
sequestration of  transfused RBCs ultimately leads to iron release from macrophages measured as NTBI in 
plasma and was previously shown to be a mediator of  transfusion-related inflammation in animals and pos-
sibly increased infection virulence in human patients (2, 31). Consistent with these findings, we observed 
maximum plasma NTBI concentrations in our model within the first 3 hours after S-RBC administration, 
with levels slowly declining over a 24-hour period. Posttransfusion increases in Tf  saturation and subse-
quent hepcidin elevation appear not to be sufficient to control excess iron in circulation (21). We have 
therefore investigated if  administration of  apo-Tf  might control NTBI accumulation in this situation. In 
our studies, infusion of  apo-Tf  at the time of  S-RBC transfusion resulted in a total Tf  plasma concentration 
of  10 mg/ml lasting up to 14 hours after infusion, followed by a decline toward baseline. These Tf  levels 
returned NTBI to baseline levels by increasing saturation of  infused apo-Tf.
Cell-free Hb has been considered as another mediator of  stored blood transfusion–related adverse 
events (13, 20). Depletion of  the vasodilator NO by the dioxygenase reaction, oxidative Hb reactions, 
and heme release are among the causative mechanisms that have been discussed (13). In our current 
study, transfusions with 9 units of  S-RBCs was associated with moderate, but sustained in vivo intravas-
cular hemolysis, which led to accumulation of  cell-free Hb in plasma. The degree of  in vivo hemolysis 
becomes particularly visual in the Hp-treated animals, in which all released Hb is captured over time 
in Hb-Hp complexes. No intravascular hemolysis occurred in the 1- and 3-unit transfusion groups, 
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Figure 4. Free iron enhances 
the oxidation of free hemo-
globin (Hb) and this biochemi-
cal reaction can be attenuated 
with increasing concentra-
tions of apo-transferrin (apo-
Tf). (A) The UV-visible spectral 
decay curves are shown for 
each of the Hb-iron-apo-
Tf mixing groups. (B) An 
acceleration in autoxidation 
rates is observed between the 
following groups: Hb versus 
Hb/Fe (n = 3, P = 0.0001); Hb/
Fe versus Hb/Fe/apo-TF (100 
μM) (n = 3, P = 0.001); Hb/Fe/
apo-TF (100 μM) versus Hb/
Fe/apo-TF (50 μM) (n = 3, P 
= 0.0001); and Hb/Fe/apo-TF 
(50 μM) versus Hb/Fe/apo-TF 
(25 μM) (n = 3, P = 0.0001). All 
statistical comparisons were 
made using an ANOVA with 
a multiple comparisons test. 
All data are presented as indi-
vidual values with the mean 
± SD. (C) 4-Hydroxynonenal 
immunochemistry of thoracic 
aorta tissue sections showing 
brown/orange immunoreactiv-
ity on adventitia and media. 
Left: Original magnification, 
×100. Scale bars: 50 μm. 
Right: Original magnification, 
×400. Scale bars: 20 μm. (D) 
4-Hydroxynonenal immuno-
chemistry of non-necrotic 
renal cortical tissue sec-
tions showing brown/orange 
immunoreactivity in the renal 
tubules. Original magnifica-
tion, ×600. Scale bars: 50 μm. 
All images were captured iden-
tically in high dynamic range 
(HDR) mode with default set-
tings. Magnification = ocular 
lens (×10) × objective.
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Figure 5. Systemic vascular and renal tissue injury following 9-unit stored red blood cell (S-RBC) transfusion following coadministration of apo-transferrin 
(apo-Tf) or haptoglobin (Hp). (A) H&E staining of thoracic aorta tissue of guinea pigs transfused with 9 units S-RBCs and stained for non-heme iron. Left: Origi-
nal magnification, ×100. Scale bars: 500 μm. Right: The arrow (top image) represents the region of the high-magnification image (bottom) showing iron deposi-
tion within the vascular wall. Original magnification, ×100 (top) and ×960 (bottom). Scale bars, 500 μm (top) and 50 μm (bottom). A, adventitia; M, media; I, 
intima. The effect of apo-Tf and Hp infusions are shown (magnification, ×100; scale bar, 500 μm). (B) Aortic injury severity score for each transfusion dose group 
(n = 10 animals). ANOVA with a multiple comparisons test was performed and results are as follows. Comparison with sham control (0 units): 0 units versus 9 
units S-RBCs (n = 10, P = 0.0001). Comparison with 9 units S-RBCs: 9 units S-RBCs versus 9 units S-RBCs + apo-Tf (n = 10, P = 0.0001); 9 units S-RBCs versus 9 
units S-RBCs + Hp (n = 10, P = 0.0001). (C) Light microscopy images of renal cortical tissue from 9-unit S-RBC–transfused stained with H&E. Original magnifi-
cation, ×200. Scale bars: 200 μm. The solid arrows show necrotic tubules with absence of nuclei, lacking intact lumen. The effect of apo-Tf and Hp dosing are 
shown. (D) Renal LCN2 (NGAL) mRNA expression in kidney tissues is presented as fold induction relative to the expression in control animals. Comparison with 
sham control (0 units): 0 units versus 9 units S-RBCs (n = 5, P = 0.0002). Comparison between 9 units S-RBCs: 9 units S-RBCs versus 9 units S-RBCs + apo-Tf (n 
= 5, P = 0.005); 9 units S-RBCs versus 9 units S-RBCs +Hp (n = 5, P = 0.0008). All data are presented as individual values with the mean ± SD. *Indicates signifi-
cant between-group differences. Magnification = ocular lens (×10) × objective.
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suggesting that cell-free Hb release occurs only at high transfusion volumes. Presumably, the splenic 
sequestration capacity for storage-damaged RBCs becomes saturated under these conditions favoring 
intravascular hemolysis.
Mechanisms similar to those discussed above may explain the data from a retrospective analysis of  
patients with cardiovascular disease receiving larger volume blood transfusion, which suggested worse out-
come in terms of  cardiovascular complications and mortality in patients receiving older-storage blood (4). 
Our experimental data are also consistent with prospective studies where lower volume transfusions of  3 to 
4 units of  blood showed no mortality difference irrespective of  the relative RBC storage period, reinforcing 
the critical impact of  dose-dependent RBC adverse outcomes (7). The vulnerability of  mice (24, 25, 32), 
lambs (15), and patients (26) with endothelial dysfunction to the pathophysiological effects of  Hb and RBC 
transfusion has been established by Zapol and colleagues. This group has also convincingly demonstrated 
that maximally stored RBCs (42-day equivalent) caused a poor resuscitation response in a mouse model of  
shock (24, 25) and a significant increase in pulmonary arterial pressure in obese volunteers (26).
Given the large accumulation of  data on the transfusion of  stored blood in animals and humans, it is 
likely novel that 2 potentially toxic mediators (iron and Hb) that arise from RBC breakdown could interact 
to enhance mortality in an animal model that is particularly susceptible to enhanced oxidative stress. Our 
preclinical data support that transfusion of  stored RBCs increases mortality in combination with vascular 
disease at maximal RBC transfusion doses. The concomitant presence of  iron and Hb is critical for the 
onset of  tissue oxidation and injury associated with death in this model. In other conditions, such as sickle 
cell disease (SCD), where hemolysis-driven NO depletion leads to tissue methemoglobin accumulation, 
vascular injury, cardiac remodeling, and pulmonary hypertension, it is not typically discussed that interac-
tion between Hb components may contribute toward alterations in the redox balance within tissue (33); 
however, the data presented here may suggest novel contributors toward vascular complication in other 
hemolytic disease states. Outcomes can be reversed by apo-Tf  and Hp such that removal of  iron or Hb 
negates the interactive toxicity. Therefore, our data suggest that increases in plasma NTBI and Hb resulting 
from stored-blood transfusion contribute to vascular disease–associated mortality though iron-enhanced 
Hb oxidation and subsequent tissue injury.
Methods
Materials
Purified human multimeric apo-Tf  and Hp were obtained from CSL Behring at concentrations of  25 mg/
ml and 100 mg/ml, respectively. An ND (TD.2040) containing complex carbohydrate (oats-wheat-alfal-
fa, 57% calories), fat (mono/poly unsaturated fat, 12%), protein (soy isolate, 31% calories), and HFSD 
(TD.110484, atherogenic guinea pig diet) containing simple carbohydrate (sucrose, 35% calories), complex 
carbohydrate (oats-wheat-alfalfa, 9% calories), fat (cocoa butter, 38% calories with 0.25% cholesterol), and 
protein (soy isolate, 18% calories) were prepared by Teklad custom research diets.
Antibodies
Rabbit polyclonal anti–4-HNE was purchased from Alpha Diagnostic (catalog HNE 12-C).
Animal studies
All animal studies were approved by the FDA/CBER Institutional Animal Care and Use Committee, with 
all experimental procedures performed in adherence to the NIH guidelines on the use of  experimental ani-
mals. Male Hartley guinea pigs weighing 300–400 g were obtained from Charles Rivers Laboratories and 
acclimated upon arrival at the FDA/CBER animal care facility (Bethesda, MD and The Federal Research 
facility at White Oak, Silver Spring, MD). Experiments in normal animals were conducted following 12 
weeks on ND, while experiments in vascular diseased animals were conducted following 12 weeks on 
HFSD as previously described (34). Animals allocated to study groups were dosed 12 hours prior to surgery 
with enrofloxacin (10 mg/kg) by the subcutaneous route. On days of  surgery, guinea pigs were dosed sub-
cutaneously with ketoprofen (5 mg/kg) for pain management after recovery and then anesthetized via the 
intraperitoneal route with a cocktail of  ketamine HCl (100 mg/kg) and xylazine HCl (5 mg/kg) (Phoenix 
Scientific Inc.). Sterilized PE50 tubing catheters were placed in the left external jugular vein, right carotid 
artery, and left femoral artery.
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Blood collection and preparation for storage and transfusion
Using aseptic technique, allogeneic blood was collected from ketamine/xylazine–anesthetized donor guin-
ea pigs via a left carotid artery catheter attached to CP2D–filled syringes (Pall Corporation). Collections 
were pooled and leukoreduced using a neonatal high-efficiency leukocyte reduction filter and storage bag 
(Purecell Neo, Pall Corporation). Blood was centrifuged at 805 g for 20 minutes and plasma was removed, 
and packed RBCs were supplemented with AS-3 (Pall Corporation). All procedures were conducted under 
sterile conditions. The final preservative concentration was equal to 14%, and storage was maintained in 
bags at 4°C over a 14-day period. F-RBCs were processed the same way, but used within 1 day of  collection.
Transfusion protocol
Male Hartley guinea pigs on HFSD (n = 10 per group) for 3 months received 0, 1, 3, or 9 units of  S-RBCs 
in donor plasma (hematocrit 40%). This is based on normal hematocrit values of  37.3% ± 0.82% (n = 20 
animals) in male Hartley guinea pigs housed in our animal facility. Volumes were administered as 1.5, 
4.5, and 13.5 ml by adding donor guinea pig plasma (0.5, 1.5, and 4.5 ml) to 60% hematocrit F-RBCs or 
S-RBCs. RBCs administered are referred to here as units rather than mls of  total volume exchange trans-
fused. Administration was carried out by sequential exchange transfusion through the jugular and carotid 
catheters by withdrawing blood at a rate of  1 ml/min (carotid catheter) and replacing RBCs/plasma at 
a rate of  1 ml/min (jugular catheter). An additional 2 groups received 9 units of  RBCs in plasma and a 
concomitant administration of  Hp or apo-Tf  (300 mg/kg, n = 10) given as a 3-ml volume over 5 minutes. 
Control groups included guinea pigs receiving ND. All animals were monitored for 7 days after transfusion. 
Moribund animals were euthanized and classified as nonsurvivors. Remaining animals were euthanized at 
7 days after transfusion and classified as survivors.
RBC storage parameters
RBCs were analyzed on day 1 (n = 4 bags) and day 14 of  storage (n = 4 bags). RBCs were measured 
using an Abaxis Vetscan VS2 (Abbott) with diagnostic-specific rotors for electrolytes, glucose, and lactate. 
RBC count, mean corpuscular volume, hematocrit, WBC count, and platelet counts were measured using 
a CELL-DYN hematology analyzer (Abbott). RBC 2,3-diphosphoglycerate was analyzed using a spec-
trophotometric assay performed according to the manufacturer’s instructions (Roche Diagnostics). RBC 
ATP was analyzed using a luminescence assay performed according to the manufacturer’s instructions 
(Abcam). RBCs were labeled with 5-chloromethylfluorescein diacetate (CellTracker Green CMFDA dye, 
Life Technologies) according to the manufacturer’s protocol. Labeled RBCs (2.5 ml) were administered to 
male Hartley guinea pigs and blood was sampled 10 minutes, 1 hour, 2 hours, 4 hours, and 24 hours there-
after. Percentage recovery was determined by dividing labeled cells remaining in circulation at 24 hours by 
labeled cells in the circulation 10 minutes following labeled RBC administration (×100).
RBC morphological evaluation
RBCs were fixed (1% glutaraldehyde in 0.1 M phosphate buffer) and postfixed with 1% osmium tetroxide for 
1 hour at room temperature. After rinsing in distilled water 3 times, samples were dehydrated in a series of  
ethanol concentrations (50%, 70%, and 95%) for 10 minutes each, followed by three 10-minute incubations in 
100% ethanol. The samples were then transferred to a pressure chamber for critical point drying (Leica EM 
CPD300) and gold coated with a high-resolution 150T S sputter coater (EMS). Morphology was examined by 
scanning electron microscopy (JEOL JSM-6390LV). RBC deformability was measured using ektacytometry 
(RheoScan-AnD 300, Rheomeditech) at the same time points. The elongation index (EI) was evaluated from 
0 to 20 pascals (Pa) and compared at 3 Pa, which is relevant to shear stress experienced by circulating RBCs.
NTBI and Hb measurements in plasma
NTBI measurement in plasma. Direct colorimetric NTBI detection of plasma (n = 10) was performed. Plasma 
samples were thawed on ice, 800 mM nitrilotriacetic acid (NTA, Sigma-Aldrich) solution (pH 7.0) was added, 
and samples were incubated for 30 minutes. The solution was then ultrafiltered using 10-kDa microfilters (Mer-
ck Millipore). HCl (1N, Thermo Fisher Scientific) and trichloracetic acid (TCA, Sigma-Aldrich) 10% in equal 
volumes were added to the ultrafiltrate. Ascorbic acid (5 mg/ml) and chromogen solution (0.508 mmol/l Fer-
roZine [HACH], 1.5 mol/l sodium acetate, and 0.1% or 1.5% (v/v) thioglycolic acid in high-purity water) were 
added. After incubation, absorbance was measured at 562 nm using a microplate reader (BioTek Synergy).
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Plasma Hb analysis. Plasma from baseline samples (n = 10) of  each animal was used to correct for back-
ground interference and turbidity and measured using a Hewlett-Packard HP-8453 rapid-scanning diode 
array spectrophotometer (Agilent Technologies). Ferrous (HbFe2+) Hb (oxy/deoxy), ferric Hb (HbFe3+), 
and hemichrome were determined using multicomponent analysis based on the extinction coefficients for 
each species, and total heme was calculated by adding these values and converting heme concentration to 
total Hb. To confirm hemolysis and subsequent Hb scavenging by Hp, we analyzed representative samples 
of  each time point in the 9-ml and 9-ml plus Hp group using size-exclusion chromatography as follows. 
Plasma samples were separated on an analytical BioSep-SEC-S3000 (600 × 7.5 mm) column (Phenomenex) 
with 50 mM potassium phosphate, pH 7.4, as the mobile phase monitored at λ = 280 nm and λ = 405 nm. 
Hb bound to Hp and unbound in plasma was determined by dividing the Hb peak area and the Hb-Hp 
peak areas by additive areas under the Hb-Hp chromatographic peak (12- to 17-minute elution) and the Hb 
chromatographic peak (21-minute elution) at λ = 405 nm.
Tissue pathology (H&E, collagen, and elastin)
Kidneys and thoracic aortas were fixed in 10% formalin for 24 hours and then stored in 100% isopropanol, 
embedded in paraffin, and 5-μm sections were prepared.
H&E. Slides were stained with alum hematoxylin, rinsed with deionized water, differentiated with 
0.3% acid alcohol, and stained with eosin for 2 minutes.
Masson’s trichrome staining (collagen). Tissue was refixed in Bouin’s solution, washed in deionized water, 
stained in Weigert’s iron hematoxylin, Biebrich scarlet-acid fuchsin solution, and finally phosphomolyb-
dic-phosphotungstic acid for differentiation. After dehydrating in graded ethanol and SafeClear (Thermo 
Fisher Scientific), slides were mounted in Permount (Thermo Fisher Scientific) and coverslipped. Images 
were obtained using an Olympus IX71 inverted microscope (Olympus America Inc.).
Verhoeff ’s Van Geisen staining (elastin fibers). Tissue slides were immersed in Verhoeff ’s hematoxylin for 
30 minutes, differentiated in 2% ferric chloride, washed with deionized water, and counterstained with Van 
Gieson’s stain for 5 minutes, dehydrated, and coverslipped. All images were captured identically in high 
dynamic range (HDR) mode with default settings.
Morphometric/image analysis
When taking images representing 1 dataset, camera or microscope settings remained unchanged to 
ensure consistency. Images of  thoracic aorta were taken at ×10 magnification and 1,200 × 1,600 pixel 
resolution; the whole tissue section was captured in 10 nonoverlapping pictures. Images of  slides stained 
by Masson’s trichrome (collagen) and Verhoeff ’s Van Geison (elastin) methods were obtained at ×100 
and ×200 magnification. Aortic tissue sections were prepared from n = 10 animals. Images were captured 
at ×200 magnification and a resolution of  1,200 × 1,600 pixels. When taking images to assess colla-
gen and elastin, the camera and microscope settings remained unchanged to ensure image consistency. 
Analysis was performed on 20 nonoverlapping images per slide (n = 5 slides/10 animals). The area of  
Masson’s trichrome (collagen, blue-stained tissue) and Verhoeff ’s Van Geison (elastin, black-stained tis-
sue) was obtained by batch analysis using ImageJ software (NIH) and divided by the total area (stained + 
nonstained), and then multiplied by 100 to give the percentage staining per image. Data are represented 
as mean ± SD percentage stained area.
4-HNE immunohistochemistry
Paraffin-embedded 5-μm sections were dewaxed, rehydrated, and heat treated in a microwave oven for 
15 minutes in 10 mM sodium citrate buffer, pH 6.0. After cooling for 30 minutes at room temperature, 
slides were washed in phosphate-buffered saline with 0.05% Tween 20 (PBST) and incubated with 
Bloxall (Vector Laboratories) for 15 minutes at room temperature to inhibit endogenous peroxidases. 
After a brief  wash, sections were blocked in 2.5% horse serum for 30 minutes at room temperature and 
then incubated overnight at 4°C with antibodies against 4-HNE (Alpha Diagnostic) in PBST containing 
2.5% horse serum. Signal was developed using polymeric peroxidase–conjugated secondary antibod-
ies (Vector ImmPRESS Kit) and DAB (SigmaFast DAB, Sigma-Aldrich). Slides were then dehydrated 
in graded ethanol and SafeClear, and mounted using Permount. All images were acquired using an 
Olympus IX71 inverted microscope equipped with an Olympus DP70 digital camera. All images were 
captured identically in HDR mode with default settings.
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Blood pressure measurements and Ach test for vascular responsiveness
Basal blood pressures were monitored for 60 minutes in ND and HFSD animals (n = 12 per group). Ach 
was administered at 5 doses ranging from 1.25 μg to 10 μg through a venous jugular catheter in conscious 
guinea pigs; blood pressure was simultaneously monitored from a carotid artery catheter coupled to a 
Gould Statham pressure transducer (Beckton Dickenson Critical Care) with data acquired using a Biopac 
MP150 data acquisition system (Biopac systems Inc.). Injection volume was normalized to 0.25 ml for each 
dose and administered over 5 minutes. The nadir mean arterial blood pressure was allowed to return to 
baseline prior to administration of  each dose.
Measurement of Hb oxidation in the presence of iron and apo-Tf
Autoxidation experiments were carried out as described previously (35). Hb (100 μM) was incubated in 
phosphate buffered saline (pH 7.4), and visible spectra (400–700 nm) were recorded at every 10 minutes 
for a 4-hour incubation at 37°C. Another set of  autoxidation experiments were performed in the presence 
of  ferrous iron (50 μM as FeSO4) alone or with Tf. The spectral changes in oxidation state over time were 
monitored in a Cary 60 temperature-controlled photodiode array spectrophotometer (Agilent). The absor-
bance changes at 576 nm due to the spontaneous oxidation of  oxyHb were plotted over time and analyzed 
by nonlinear least-square curve fitting to single- or double-exponential equations using Microsoft Excel to 
obtain oxidation rates. Mean oxidation rates with SDs were obtained by averaging data from at least 3 dif-
ferent sets of  experiments.
Statistics
Data are represented as mean ± SD for parametric data. A Shapiro-Wilk test was performed to determine 
normal distribution of  data. For parametric data, planned comparisons between RBC doses, Hp, and apo-
Tf  treatment (n = 10/group or as indicated in figure legends for individual assays) were analyzed using a 
1-way ANOVA with Bonferroni’s correction for multiple comparisons. Group comparison for basal diet 
changes were analyzed using an unpaired Student’s t test. Blood storage parameters analysis was performed 
using a paired Student’s t test and represented as mean ± SD with the 95% CI. Survival proportions for 
transfused ND and HFSD guinea pigs (n = 10/group) were analyzed using a log-rank (Mantel-Cox) test. 
All statistical analysis was performed using GraphPad Prism version 6.1.
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